GH
Guardant Health
GH · NASDAQ
$162.78 +1.36% (+$2.18)
1M -1.40%
Market Cap $21.8B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$110.73
32.0% downside
Trenutna cena
$162.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GH trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 18.46x
P/FFO N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 29.75%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 38.33%
Op. margin 39.75%
FCF margin 20.35%
Quality
11 /100
Poor ROA 23.71%
Asset turnover 0.62x
ROIC 29.30%
Debt
43 /100
Moderate Int. coverage -93.37x
Current ratio 4.03x
Net debt/EBITDA N/A
Stability
67 /100
Stable Rev. volatility 3.87%
EPS volatility 13.37%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GH
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Helmy Eltoukhy
Employees
2,498
Headquarters
Palo Alto
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report